Healthy Gestational Weight Gain Programme
The Effects of Mobile Health Based Lifestyle Intervention on Gestational Weight Gain in Pregnant Women With Overweight and Obesity: A Randomized Controlled Trial
1 other identifier
interventional
200
1 country
2
Brief Summary
This study aims to evaluate the efficacy of a multi-component lifestyle interventions during pregnancy on promoting appropriate gestational weight gain, preventing GDM, and improving pregnancy, delivery, and neonatal outcomes among overweight or obese pregnant women. The intervention strategies are developed based on the transtheoretical model and mobile health (via WeChat Public Account in smartphone), and will be conducted online and offline. This study will recruit and follow-up 200 overweight or obese singleton pregnant women (pre-pregnancy 24kg/m2≤BMI≤40 kg/m2) during the first trimester of pregnancy from Weifang Maternal and Child Health Hospital, Shandong Province, China, and Tongzhou Maternal and Child Health-care Institution, Beijing, China, with 100 pregnancy women in each institution. The 200 overweight or obese pregnant women will be randomly allocated at a 1:1 ratio to either the intervention or control group, stratified by the categorical variables of age, BMI and parity. Participants in the control group will be provided usual prenatal care. The lifestyle intervention will last for approximately 6 months (from 10-14 weeks to 32-36 weeks of gestation). Follow-up timepoints included 8-14 weeks of gestation, 24-28 weeks of gestation, 32-36 weeks of gestation. The interventions are composed of health education related to gestational weight gain and healthy lifestyles, diet modification, active physical activity, regular individual in-person and telephone sessions, diet behavior monitoring, physical activity monitoring, and weight monitoring with Huawei Wristband and WeChat Public Account. The hypothesis is that lifestyle interventions based on the transtheoretical model and mobile health will result in more appropriate gestational weight gain and lower risk of adverse pregnancy outcomes compared with usual care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedStudy Start
First participant enrolled
April 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedApril 13, 2026
March 1, 2026
12 months
March 31, 2024
April 8, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Total gestational weight gain
Weight at gestational week 32-36 minus pre-pregnancy weight (kilograms)
From pre-pregnancy to gestational week 32-36
Gestational weight gain before OGTT screening
Gestational weight gain before OGTT screening at 24-28 weeks (kilograms)
From pre-pregnancy to midterm (24-28 weeks)
Secondary Outcomes (8)
Weekly rate of gestational weight gain between study clinical assessments
Gestational weight gain from pre-pregnancy/baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)
Proportion of women who exceed the IOM guidelines' weekly rate of gestational weight gain between clinical assessments
From pre-pregnancy/baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)
Rate of Gestational Diabetes Mellitus diagnosed according to International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria
OGTT screening at 24-28 gestational weeks
Rate of Preeclampsia/Gestational hypertension
From 20 weeks of gestation to delivery
Rate of Cesarean Section
At delivery
- +3 more secondary outcomes
Other Outcomes (17)
Change of Blood pressure
From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)
Change of body fat percentage (%)
From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)
Change of fat free mass (kg)
From baseline (8-14 weeks) to midterm (24-28 weeks)/terminal (32-36 weeks)
- +14 more other outcomes
Study Arms (2)
lifestyle intervention
EXPERIMENTALHealth education: Individual face to face or telephone sessions and online health education material. Diet behavior: The eight eating behavioral goals will be assigned to each participant with two for every 4-week cycle. Physical activity: Women will be advised to gradually attaining the goal of 150 minutes of moderate- to vigorous-intensity physical activity per week and walk at least 6000 steps per day. Weight monitoring: Self-monitoring of weight gain (regular self-weighing) and weight logging at least once a week was recommended.
usual-care control
NO INTERVENTIONProvision of usual prenatal care
Interventions
The investigators set diet, physical activity, and weight goals for each participant. During the lifestyle intervention period, the participants need to complete weekly self-monitoring of weight, weekly recording of diet behavioral goals, timely exercise logging, online health education course learning by using the WeChat public account. They will receive corresponding timely reminder and tailored feedback in the form of graphical illustration and text according to diet, physical activity, and weight data collected by WeChat public account and Huawei Wristband. They will receive individual face to face or telephone sessions every 2 weeks to complete health education, goal review, motivational interview as well as collecting adverse events.
Eligibility Criteria
You may qualify if:
- At 8-14 weeks of gestation
- Overweight or obese (pre-pregnancy 40 kg/m2≥BMI≥24 kg/m2) based on BMI recommendations of the Group of China Obesity Task Force of the Chinese Ministry of Health accounting for interracial differences (overweight BMI 24-28 kg/m2 and obese BMI≥28kg/m2)
- years of age
- Singleton pregnant
- Skilled at using smartphones and WeChat during pregnancy
- Attend regular antenatal care and plan delivery at W.F. Maternal and Child Health Hospital or Tongzhou Maternal and Child Health-care Institution of Beijing
- No contraindications to physical activity according to Physical Activity Readiness Questionnaire (PAR-Q)
- Willing to be randomized and cooperate with research and regular follow-up visits and sign informed consent.
You may not qualify if:
- Pre-pregnancy hypertension, severe cardiovascular and cerebrovascular diseases, respiratory disease, hepatic and renal disease, malignant tumors, systemic lupus erythematosus, thyroid disease, severe anemia, and other chronic consumptive diseases.
- Cervical insufficiency (historical painless cervical dilation leading to recurrent second-trimester births in the absence of other causes; dilated cervix on manual or speculum examination, etc.), multiple pregnancy, or continuous vaginal bleeding, etc.
- Diabetes before pregnancy
- Special dietary needs (e.g. , vegetarianism)
- Severe psychiatric disorders (serious mental health disorders including depression, anxiety, bipolar disorders, etc.)
- Cognitive impairment, visual impairment or hearing impairment
- History of bariatric surgery or surgical history involving important organs within 3 months
- Participated in other clinical trials within 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Tongzhou Maternal and Child Health-care Institution
Beijing, Beijing Municipality, China
W.F. Maternal and Child Health Hospital;
Weifang, Shandong, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Haixue Wang, Doctor
Peking University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 31, 2024
First Posted
April 17, 2024
Study Start
April 19, 2024
Primary Completion
March 31, 2025
Study Completion
March 31, 2026
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share